Influence of Nonclinical Factors on Choice of Therapy for Early Hepatocellular Carcinoma |
| |
Authors: | Hari Nathan MD PhD Dorry L Segev MD PhD John F P Bridges PhD Allan B Massie MHS Andrew M Cameron MD PhD Kenzo Hirose MD Richard D Schulick MD Michael A Choti MD MBA Timothy M Pawlik MD MPH PhD |
| |
Institution: | 1. Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA 2. Department of Health Policy and Management, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
|
| |
Abstract: | Background Initial therapy for early hepatocellular carcinoma (HCC) with well-compensated cirrhosis is controversial. While we previously reported on the effect of clinical factors and surgeon specialty on choice of therapy for early HCC, other nonclinical factors also may impact decision-making. Methods Surgeons who treat HCC were invited to complete a web-based survey that included ten case scenarios. Choice of therapy—liver transplantation (LT), liver resection (LR), or radiofrequency ablation (RFA)—was analyzed using regression models. Results There were 336 responses for analysis. Most respondents were in academic centers (86 %) that offered LT (71 %). The median number of patients annually evaluated for HCC was 30. Both practice type and HCC case volume were associated with choice of therapy, but these associations were not independent of surgeon specialty. LT surgeons who did not also perform RFA were less likely than those LT surgeons who did offer RFA to choose RFA over LT (relative risk ratios (RRR) 0.38, P < 0.001). Non-LT surgeons were more likely than LT surgeons who also offered RFA to choose RFA over LT (RRR 2.24, P < 0.001). Surgeons who worked at hospitals where LT was performed were much more likely to choose LT over LR and RFA even if they did not personally perform LT (RRR 1.27 and RRR 3.33, P < 0.001). Conclusions Surgeon- and institution-related factors impact choice of therapy for early HCC even after adjustment for differences in clinical presentation. These data suggest that choice of therapy for patients with early HCC varies across providers independent of case selection. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|